The Cytokines of Asthma
Reads0
Chats0
TLDR
The cytokine networks driving asthma are reviewed, placing these in cellular context and incorporating insights from cytokine-targeting therapies in the clinic, to argue that the development of new and improved therapeutics will require understanding the diverse mechanisms underlying the spectrum of asthma pathologies.About:
This article is published in Immunity.The article was published on 2019-04-16 and is currently open access. It has received 501 citations till now. The article focuses on the topics: Bronchial hyperresponsiveness & Systemic inflammation.read more
Citations
More filters
Journal ArticleDOI
Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?
TL;DR: Akdis et al. as discussed by the authors introduced an extended "epithelial barrier hypothesis" which proposes that the increase in epithelial barrier-damaging agents linked to industrialization, urbanization and modern life underlies the rise in allergic, autoimmune and other chronic conditions.
Journal ArticleDOI
The basic immunology of asthma
Hamida Hammad,Bart N. Lambrecht +1 more
TL;DR: In this article, the underlying immunological basis of various asthma endotypes by discussing results obtained from animal studies as well as results generated in clinical studies targeting specific immune pathways is discussed.
Journal ArticleDOI
The cytokine network involved in the host immune response to periodontitis
TL;DR: This review begins with an up-to-date aetiological hypothesis of periodontal disease and summarize the roles of cytokines in the host immune response and the latest cytokine-related therapeutic measures for periodontic disease.
Journal ArticleDOI
Type 2 immunity in the skin and lungs.
Cezmi A. Akdis,Peter D. Arkwright,Marie-Charlotte Brüggen,William W. Busse,Massimo Gadina,Emma Guttman-Yassky,Emma Guttman-Yassky,Kenji Kabashima,Kenji Kabashima,Yasutaka Mitamura,Laura Vian,Jianni Wu,Jianni Wu,Oscar Palomares +13 more
TL;DR: The present review aims to highlight recent advances in type 2 immunity and discuss the cellular sources, targets, and roles of type 2 mechanisms in asthma and AD.
Posted ContentDOI
FinnGen: Unique genetic insights from combining isolated population and national health register data
Mitja I. Kurki,Juha Karjalainen,Priit Palta,T. P. Sipilampauml,Kati Kristiansson,Kati Donner,Mary Pat Reeve,Hannele Laivuori,Mervi Aavikko,Mari A. Kaunisto,Anu Loukola,Elisa Lahtela,Hannele Mattsson,Päivi Laiho,P. della Briotta Parolo,Arto Lehisto,Masahiro Kanai,Nina Mars,J. RaÌmoÌ,Tuomo Kiiskinen,Henrike O. Heyne,Kumar Veerapen,S. RuÌeger,S. LemmelaÌ,W. Zhou,Sanni Ruotsalainen,K. PaÌrn,Tero Hiekkalinna,Sami Koskelainen,Tuula A. Paajanen,Victor Llorens,Javier Gracia-Tabuenca,Harri Siirtola,Katherine Reis,Adel Elnahas,K. Aalto-SetaÌlaÌ,Kaur Alasoo,Muhammed Ikbal Arvas,Kirsi Auro,Shrayashi Biswas,A. Bizaki-Vallaskangas +40 more
TL;DR: The power of bottlenecked populations to find unique entry points into the biology of common diseases through low-frequency, high impact variants is demonstrated.
References
More filters
Journal ArticleDOI
Dupilumab in persistent asthma with elevated eosinophil levels.
Sally E. Wenzel,Linda B. Ford,David S. Pearlman,Sheldon L. Spector,Lawrence Sher,Franck Skobieranda,Lin Wang,Stephane C. Kirkesseli,Ross E. Rocklin,Brian Bock,Jennifer D. Hamilton,Jeffrey Ming,Allen Radin,Neil Stahl,George D. Yancopoulos,Neil M.H. Graham,Gianluca Pirozzi +16 more
TL;DR: In patients with persistent, moderate-to-severe asthma and elevated eosinophil levels who used inhaled glucocorticoids and LABAs, dupilumab therapy, as compared with placebo, was associated with fewer asthma exacerbations when LABs and inhaled GLPAs were withdrawn, with improved lung function and reduced levels of Th2-associated inflammatory markers.
Journal ArticleDOI
Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions.
TL;DR: Bronchoalveolar lavage was performed in 19 asthmatic patients and in 5 control subjects to suggest that eosinophils and their mediators might be involved in the development of LAR after allergen inhalation.
Journal ArticleDOI
Type 2 inflammation in asthma — present in most, absent in many
TL;DR: How dichotomizing asthma according to levels of type 2 inflammation — into 'T helper 2 (TH2)-high' and 'TH2-low' subtypes (endotypes) — has shaped the thinking about the pathobiology of asthma and has generated new interest in understanding the mechanisms of disease that are independent of type 1 inflammation is considered.
Journal ArticleDOI
Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161.
Jenny Mjösberg,Sara Trifari,Sara Trifari,Natasha K Crellin,Natasha K Crellin,Charlotte P. Peters,Cornelis M. van Drunen,Berber Piet,Wytske Fokkens,Tom Cupedo,Hergen Spits +10 more
TL;DR: This work describes another lineage-negative CD127+CD161+ ILC population found in humans that expressed the chemoattractant receptor CRTH2 and identifies a unique type of human ILC that provides an innate source of T helper type 2 (TH2) cytokines.
Journal ArticleDOI
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells.
Hamida Hammad,Marcello Chieppa,Frédéric Perros,Monique Willart,Ronald N. Germain,Bart N. Lambrecht,Bart N. Lambrecht +6 more
TL;DR: It is shown in irradiated chimeric mice that Toll-like receptor 4 expression on radioresistant lung structural cells, but not on DCs, is necessary and sufficient for DC activation in the lung and for priming of effector T helper responses to HDM.
Related Papers (5)
Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma
Mario Castro,Jonathan Corren,Ian D. Pavord,Jorge Maspero,Sally E. Wenzel,Klaus F. Rabe,William W. Busse,Linda B. Ford,Lawrence Sher,J. Mark FitzGerald,Constance H. Katelaris,Yuji Tohda,Bingzhi Zhang,Heribert Staudinger,Gianluca Pirozzi,Nikhil Amin,Marcella Ruddy,Bolanle Akinlade,Asif Khan,Jingdong Chao,Renata Martincova,Neil M.H. Graham,Jennifer D. Hamilton,Brian N. Swanson,Neil Stahl,George D. Yancopoulos,Ariel Teper +26 more